Glenon
Glenon v. Abbott Laboratories
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA DJ GLENON, individually and on behalf Case No.: 22-cv-2061-AGS-DEB of others similarly situated,
ORDER DENYING DEFENDANT’S
Plaintiff, MOTION TO DISMISS THE v. AMENDED COMPLAINT (ECF 14)
ABBOTT LABORATORIES,
7 Defendant.
In this putative class action, plaintiff alleges that defendant Abbott Laboratories disclosed medical information about him and hundreds of other patients in a mass email. Abbott moves to dismiss. BACKGROUND1 In 2022, Synovation Medical Group shared with defendant Abbott Laboratories a patient list of 375 chronic-pain patients. (ECF 11, at 4; ECF 19, at 8.) Abbott sent a group email to those patients—including plaintiff DJ Glenon—that revealed all the recipients’ email addresses. (ECF 11, at 4.) In addition, Glenon alleges that the email, excerpted below, implicitly exposed his chronic-pain condition and his health-care provider: Hello!
19 Synovation Medical Group is welcoming a new physician . .…